Western blot analysis showed that the ERK1/2 and JNK inhibitors specifically inhibited CF-induced ERK1/2 autophosphorylation and c-jun (a direct downstream target phosphorylated by JNK) phosphorylation, respectively (Fig. 3B). The gene discussed is MAPK8; the disease is cystic fibrosis.